Group One Trading’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
Other funds holding LFCR
Group One Trading's LFCR Position: Q3 2026 in Review
Group One Trading increased its Lifecore Biomedical (LFCR) stake by 93% in Q3 2026, buying an estimated $13K and bringing the position to 5,798 shares worth $38.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5436.
Group One Trading first reported a position in LFCR in Q2 2013 and has held it in 13 quarters since. The position peaked at $113K in Q3 2023. 105 funds tracked by Wall St. Rank hold LFCR as of Q3 2026.
- Group One Trading held 5,798 shares of Lifecore Biomedical worth $38.2K as of Q3 2026.
- Group One Trading bought 2,800 Lifecore Biomedical shares in Q3 2026, an estimated $13K.
- Lifecore Biomedical made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #5436 holding.
- Group One Trading first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 13 quarters since.
- Group One Trading's Lifecore Biomedical position peaked at $113K in Q3 2023.
- 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.